Anthem Biosciences IPO Allotment Today On July 17: How to Check Status, GMP, Listing Details, and More

The initial public offering (IPO) allotment status for Anthem Biosciences is expected to be finalized today, Thursday, July 17, 2025, following a highly successful public offering.

Investors who applied for shares can check whether they have received an allotment through the official websites of BSE, NSE, or the IPO registrar Kfin Technologies.

Those who will allotted shares will receive them in their demat accounts by July 18, while refunds for unallotted applicants will also be initiated on the same day. The company's shares are likely to be listed on the stock exchanges, BSE and NSE on Monday, July 21, 2025.

How to Check Anthem Biosciences IPO Allotment Status Online?

You can check your allotment status using either your PAN, Application Number, or Demat Account Details.

On NSE Website:

1. Go to: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
2. Select 'Equity & SME IPO bid details'
3. From the 'Select Symbol' dropdown, choose 'ANTHEM'
4. Enter your personal details such as PAN and application number
5. Click on the 'Submit' button

On BSE Website:

1. Go to: https://www.bseindia.com/investors/appli_check.aspx
2. Select 'Equity' as the Issue Type
3. Choose 'Anthem Biosciences Ltd' from the dropdown
4. Enter your Application Number or PAN
5. Tick the CAPTCHA box and click 'Search'

On Kfin Technologies Website:

1. Visit: https://ris.kfintech.com/ipostatus/
2. Choose any of the available links
3. Select 'Anthem Biosciences' from the dropdown
4. Enter PAN/Application No./DP Client ID
5. Click 'Submit' to view your status

IPO Subscription Details

Anthem Biosciences IPO received a very strong response from investors and was subscribed 67.42 times overall. Among the different investor groups, Qualified Institutional Buyers (QIBs) subscribed 192.80 times, Non-Institutional Investors (NIIs) subscribed 44.70 times, and the Retail Investor portion was subscribed 5.98 times. The employee quota was subscribed 6.99 times.

Brokerage firms like Anandrathi, Nirmal Bang, Canara Bank, Axis Capital and few others had recommended Buy for the IPO.

This strong response is also reflected in the grey market premium (GMP), which rose during the bidding window, suggesting positive listing expectations.

Anthem Biosciences IPO GMP

As per market sources like Investorgain, the grey market premium (GMP) for Anthem Biosciences is around Rs 151 per share. Based on the issue price of Rs 570, this puts the estimated listing price at Rs 721, showing a 26.49% premium.

Anthem Biosciences IPO Details

The IPO opened for subscription on July 14, 2025, and closed on July 16, 2025. The total IPO size was Rs 3,395 crore, and it was an Offer for Sale (OFS), meaning the company itself will not receive any of the proceeds, these will go to the existing shareholders selling their stakes.

The price band for the IPO was set between Rs 540 and Rs 570 per share.

About Anthem Biosciences

Founded in 2006 and based in Bengaluru, Anthem Biosciences is a global Contract Research, Development and Manufacturing Organisation (CRDMO). It offers end-to-end solutions to pharmaceutical and biotech companies, from early-stage research to large-scale commercial manufacturing.

The firm specializes in complex, fermentation-based APIs like peptides, enzymes, and biosimilars. It serves over 44 countries, including major markets like the US, Europe, and Japan, with clients ranging from biotech startups to global pharma giants.

In FY 2024-25, the company posted revenue of Rs 1,844.55 crore and a net profit of Rs 451 crore, with strong margins of 23.4%.